{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:21:04Z","timestamp":1789928464858,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.annder.2016.10.010","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T13:03:49Z","timestamp":1484571829000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Maladie de Fabry"],"prefix":"10.1016","volume":"144","author":[{"given":"F.","family":"Stephan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2016.10.010_bib0380","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.1898.tb16317.x","article-title":"A case of \u201cAngio-Keratoma\u201d","volume":"10","author":"Anderson","year":"1898","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2016.10.010_bib0390","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/qjmed\/95.10.647","article-title":"New developments in the management of Anderson-Fabry disease","volume":"95","author":"Mehta","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.annder.2016.10.010_bib0395","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry's disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid","volume":"238","author":"Sweeley","year":"1963","journal-title":"J Biol Chem"},{"key":"10.1016\/j.annder.2016.10.010_bib0400","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2741","article-title":"Fabry's disease: alphagalactosidase A deficiency","author":"Desnick","year":"1995"},{"key":"10.1016\/j.annder.2016.10.010_bib0405","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2016.10.010_bib0410","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0415","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archderm.140.12.1440","article-title":"Fabry disease: a study of 6\u00a0hemizygous men and 5\u00a0heterozygous women with emphasis on dermatologic manifestations","volume":"140","author":"Larralde","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jmg.27.5.303","article-title":"A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations","volume":"27","author":"Hasholt","year":"1990","journal-title":"J Med Genet"},{"key":"10.1016\/j.annder.2016.10.010_bib0425","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60\u00a0obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.annder.2016.10.010_bib0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1651-2227.2006.tb02186.x","article-title":"Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey","volume":"95","author":"Ramaswami","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.annder.2016.10.010_bib0435","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"Q J Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0440","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.ki.5002677","article-title":"Fabry disease: an underrecognized cause of proteinuria","volume":"73","author":"Fervenza","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.annder.2016.10.010_bib0445","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.annder.2016.10.010_bib0450","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"Von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0455","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.annder.2016.10.010_bib0460","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2362.2008.01921.x","article-title":"Misleading terms in Anderson-Fabry disease","volume":"38","author":"Weidemann","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.annder.2016.10.010_bib0465","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry Outcome Survey","volume":"157","author":"Orteu","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0470","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366\u00a0patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.annder.2016.10.010_bib0475","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98\u00a0hemizygous males","volume":"38","author":"MacDermott","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.annder.2016.10.010_bib0480","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00128071-200304030-00005","article-title":"Fabry disease: recognition and management of cutaneous manifestations","volume":"4","author":"Mohrenschlager","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3233\/CH-2009-1158","article-title":"Nailfold capillaroscopy: specific features in Fabry disease","volume":"42","author":"Wasik","year":"2009","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.annder.2016.10.010_bib0490","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1346-8138.1991.tb03140.x","article-title":"Transepidermal elimination of thrombi in three cases of thrombotic angiokeratoma: an incidental histopathologic finding of angiokeratoma","volume":"18","author":"Bang","year":"1991","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0495","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352\u00a0pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.annder.2016.10.010_bib0500","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00401-005-0026-8","article-title":"Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients","volume":"111","author":"Navarro","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.annder.2016.10.010_bib0505","first-page":"871","article-title":"Sur une singuli\u00e8re malformation familiale de l\u2019\u00e9pith\u00e9lium r\u00e9nal","volume":"94","author":"Hamburger","year":"1964","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.annder.2016.10.010_bib0510","first-page":"46","article-title":"Fabry disease and angiokeratoma corporis diffusum are not synonymous: cutaneous vascular lesions and facial features in 100\u00a0patients with Fabry disease","volume":"161","author":"Orteu","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0515","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2133.2012.10742.x","article-title":"Angiokeratoma: decision-making aid for the diagnosis of Fabry disease","volume":"166","author":"Zampetti","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0520","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-9343(65)90086-0","article-title":"Angiokeratoma corporis diffusum universale (Fabry)","volume":"39","author":"Wallace","year":"1965","journal-title":"Am J Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0525","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000246270","article-title":"Angiokeratomas: an update","volume":"193","author":"Schiller","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2016.10.010_bib0530","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ejhg.2009.35","article-title":"Hereditary haemorrhagic telangiectasia: a clinical and scientific review","volume":"17","author":"Govani","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.annder.2016.10.010_bib0535","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2340\/00015555745456","article-title":"Carbonic anhydrase is abundant in fenestrated capillaries of cherry hemangioma","volume":"74","author":"Eichhorn","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2016.10.010_bib0540","first-page":"475","article-title":"Coexistence of Fabry's disease and systemic lupus erythematosus","volume":"16","author":"Rahman","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0545","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/01443611003698703","article-title":"Vulvar angiokeratoma","volume":"30","author":"Nomelini","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.annder.2016.10.010_bib0550","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1346-8138.2006.00115.x","article-title":"Angiokeratoma circumscriptum arranged in a systematized band-like pattern suggesting mosaicism","volume":"33","author":"Bechara","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0555","first-page":"255","article-title":"Angiokeratoma: apropos of 93\u00a0cases","volume":"16","author":"Naranjo Sintes","year":"1988","journal-title":"Med Cutan Iber Lat Am"},{"key":"10.1016\/j.annder.2016.10.010_bib0560","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archderm.142.5.615","article-title":"Angiokeratoma corporis diffusum in a patient with no recognizable enzyme abnormalities","volume":"142","author":"Kelly","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0565","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry's disease: impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2016.10.010_bib0570","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1742-1241.2006.01061.x","article-title":"Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey","volume":"60","author":"Lidove","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.annder.2016.10.010_bib0575","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.gim.0000200950.25118.dd","article-title":"Quantitative dysmorphology assessment in Fabry disease","volume":"8","author":"Ries","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0580","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/153968503768330229","article-title":"Severe lymphatic microangiopathy in Fabry disease","volume":"1","author":"Amann-Vesti","year":"2003","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.annder.2016.10.010_bib0585","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/adc.43.227.73","article-title":"Angiokeratoma corporis diffusum: some clinical aspects","volume":"43","author":"Johnston","year":"1968","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.annder.2016.10.010_bib0590","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.ASN.0000015239.57436.18","article-title":"Anderson-Fabry disease: extrarenal, neurologic manifestations","volume":"13","author":"Kolodny","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.annder.2016.10.010_bib0595","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.23.8.871","article-title":"Relief of pain of Fabry's disease by diphenylhydantoin","volume":"23","author":"Lockman","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2016.10.010_bib0600","first-page":"399","article-title":"Anderson-Fabry disease\u00a0\u2013\u00a0Angiokeratoma corporis diffusum universal","volume":"66","author":"Radcliffe","year":"1990","journal-title":"Genitourin Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0605","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2190\/JKFW-3WXK-QA7N-BYLN","article-title":"Psychiatric disorders in patients with Fabry's disease","volume":"23","author":"Grewal","year":"1993","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0610","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/art.1780220715","article-title":"The arthropathy of Fabry's disease","volume":"22","author":"Sheth","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2016.10.010_bib0615","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.annder.2016.10.010_bib0620","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.annder.2016.10.010_bib0625","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1012475908718","article-title":"Renal disease in Fabry patients","volume":"24","author":"Grunfeld","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2016.10.010_bib0630","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.annder.2016.10.010_bib0635","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Gastrointestinal symptoms in 342\u00a0patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0640","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.annder.2016.10.010_bib0645","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10545-007-0616-9","article-title":"Natural history of the respiratory involvement in Anderson-Fabry disease","volume":"30","author":"Magage","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2016.10.010_bib0650","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","article-title":"Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy","volume":"254","author":"Palla","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.annder.2016.10.010_bib0655","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1523-1755.2005.00294.x","article-title":"Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey","volume":"67","author":"Kleinert","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.annder.2016.10.010_bib0660","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.annder.2016.10.010_bib0665","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-005-0003-3","article-title":"High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease","volume":"28","author":"Hauser","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2016.10.010_bib0670","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2133.2004.05813.x","article-title":"Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion","volume":"150","author":"Linthorst","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2016.10.010_bib0675","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pd.1767","article-title":"Prenatal diagnosis of Fabry disease","volume":"27","author":"Desnick","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.annder.2016.10.010_bib0680","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1015511908710","article-title":"Quality of life of patients with Fabry disease","volume":"11","author":"Gold","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.annder.2016.10.010_bib0685","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0690","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1523-1755.63.s84.5.x","article-title":"Fabry disease: diagnosis and treatment","volume":"63","author":"Breunig","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.annder.2016.10.010_bib0695","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM197307052890103","article-title":"Replacement therapy for inherited enzyme deficiency","volume":"289","author":"Brady","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0700","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.annder.2016.10.010_bib0705","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2016.10.010_bib0710","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.annder.2016.10.010_bib0715","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.286.11.1315","article-title":"Skin manifestations of Fabry disease","volume":"286","author":"M\u00f6hrenschlager","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2016.10.010_bib0720","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2009.11.007","article-title":"Four year prospective clinical trial of agalsidase alfa in children with Fabry disease","volume":"156","author":"Schiffmann","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.annder.2016.10.010_bib0725","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10545-005-0018-9","article-title":"Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa","volume":"28","author":"Wendt","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.annder.2016.10.010_bib0730","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/GIM.0b013e3181981d82","article-title":"Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta, during enzyme replacement therapy in patients with Fabry disease","volume":"11","author":"Lubanda","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0735","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2016.10.010_bib0740","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mt.2009.220","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue globotriaosylceramide level in a mouse model of Fabry disease","volume":"18","author":"Khanna","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.annder.2016.10.010_bib0745","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1073\/pnas.1002758107","article-title":"Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders","volume":"107","author":"Meng","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annder.2016.10.010_bib0375","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/10430349950017671","article-title":"Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer","volume":"10","author":"Ziegler","year":"1999","journal-title":"Hum Gene Ther"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816311012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816311012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:05:00Z","timestamp":1758971100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963816311012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0151963816311012"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2016.10.010","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladie de Fabry","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}